Quick Takeaways: Why It Matters? Loyal’s completion of the RXE efficacy requirement for LOY‑003 means all three of its canine longevity candidates (LOY‑001, LOY‑002, LOY‑003) have now met the FDA’s efficacy bar under the Expanded Conditional Approval pathway, putting the compan...
